Phase 1 Trials

Safety and Efficacy Drug Development Vaccine Safety Chronic Weight Management Patient Monitoring ADC Clinical Studies Drug Evaluation Vaccine Development Vaccine Trials Oncology Trials

7 ARTICLES

2mo ago

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Backed by a $650 million up-front payment, the agreement places Pfizer in charge of global development for a 12-program cancer portfolio discovered and advanced by Innovent.

6 ARTICLES

3mo ago

Cellular Intelligence Takes Global Rights to Novo Nordisk’s Parkinson’s Cell Therapy

6 ARTICLES

5mo ago

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

4 ARTICLES

6mo ago

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

6 ARTICLES

6mo ago

After Two Nipah Cases in India, WHO Sees Low Global Risk as Vaccine Work Advances

8 ARTICLES

8mo ago

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

3 ARTICLES

8mo ago

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

4 ARTICLES

9mo ago

Single-Infusion CRISPR Therapy Lowers LDL and Triglycerides in First Human Trial

12 ARTICLES

9mo ago

One-Time CRISPR Edit Halves LDL and Triglycerides in Early Human Trial

6 ARTICLES

last yr.

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

5 ARTICLES

last yr.

Engineered Gut Microbe for Kidney Stones Gets Triple Safeguard After Mutation Concerns

11 ARTICLES

last yr.

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Phase 1 Trials

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Cellular Intelligence Takes Global Rights to Novo Nordisk’s Parkinson’s Cell Therapy

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

After Two Nipah Cases in India, WHO Sees Low Global Risk as Vaccine Work Advances

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

Single-Infusion CRISPR Therapy Lowers LDL and Triglycerides in First Human Trial

One-Time CRISPR Edit Halves LDL and Triglycerides in Early Human Trial

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Engineered Gut Microbe for Kidney Stones Gets Triple Safeguard After Mutation Concerns

Glenmark Stock Hits Record High on $700 Million AbbVie Cancer Drug Deal

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Xenon Gas Shows Promise as Potential Alzheimer's Treatment in Mouse Study

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Never miss stories about

Phase 1 Trials